16 July 2019 2 Min Read
Cancer drugs help Johnson & Johnson raise sales outlook
Pharmaceuticals unit has cushioned the impact of slow growth in its medical device and consumer health units
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In